SEC 13F Intelligence

S&Co Inc / RPRX

S&Co Inc’s Royalty Pharma PLC Position

Does S&Co Inc own Royalty Pharma PLC (RPRX)? Yes — 358.4K shares worth $17M (+1.07% of its 13F portfolio) as of Q1 2026.

Position Value
$17M
Q1 2026
Shares
358.4K
% of Portfolio
+1.07%
Quarters Held
22
currently held

Position History RPRX

Reported value by quarter
Q4 ’20: $3MQ4 ’20Q1 ’21: $3MQ2 ’21: $3MQ3 ’21: $3MQ3 ’21Q4 ’21: $6MQ1 ’22: $6MQ2 ’22: $7MQ2 ’22Q3 ’22: $6MQ4 ’22: $6MQ1 ’23: $6MQ1 ’23Q2 ’23: $7MQ3 ’23: $7MQ4 ’23: $9MQ4 ’23Q1 ’24: $10MQ2 ’24: $9MQ3 ’24: $10MQ3 ’24Q4 ’24: $9MQ1 ’25: $11MQ2 ’25: $13MQ2 ’25Q3 ’25: $13MQ4 ’25: $14MQ1 ’26: $17MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026358.4K$17M+1.07%
Q4 2025358.4K$14M+0.86%
Q3 2025358.2K$13M+0.77%
Q2 2025358.2K$13M+0.83%
Q1 2025358.2K$11M+0.75%
Q4 2024358.2K$9M+0.62%
Q3 2024362.5K$10M+0.67%
Q2 2024358.3K$9M+0.66%
Q1 2024341.1K$10M+0.73%
Q4 2023332.1K$9M+0.72%
Q3 2023253.6K$7M+0.57%
Q2 2023224.2K$7M+0.56%
Q1 2023152.9K$6M+0.47%
Q4 2022159.9K$6M+0.55%
Q3 2022159.9K$6M+0.58%
Q2 2022159.9K$7M+0.57%
Q1 2022159.9K$6M+0.44%
Q4 2021145.2K$6M+0.41%
Q3 202192.8K$3M+0.26%
Q2 202161.3K$3M+0.20%
Q1 202158.7K$3M+0.22%
Q4 202057.6K$3M+0.26%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See S&Co Inc’s full portfolio or all institutional holders of RPRX.